Protagenic Therapeutics Statistics
Total Valuation
PTIX has a market cap or net worth of $5.72 million. The enterprise value is $1.67 million.
| Market Cap | 5.72M |
| Enterprise Value | 1.67M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PTIX has 4.44 million shares outstanding. The number of shares has increased by 0.62% in one year.
| Shares Outstanding | 4.44M |
| Shares Change (YoY) | +0.62% |
| Shares Change (QoQ) | +1.45% |
| Owned by Insiders (%) | 21.83% |
| Owned by Institutions (%) | 7.96% |
| Float | 3.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.56 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.41, with zero debt.
| Current Ratio | 6.41 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.44 |
Financial Efficiency
Return on equity (ROE) is -101.80% and return on invested capital (ROIC) is -123.41%.
| Return on Equity (ROE) | -101.80% |
| Return on Assets (ROA) | -82.20% |
| Return on Capital (ROIC) | -123.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.00M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.97% in the last 52 weeks. The beta is 0.38, so PTIX's price volatility has been lower than the market average.
| Beta (1Y) | 0.38 |
| 52-Week Price Change | -29.97% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 41.19 |
| Average Volume (30 Days) | 10,443 |
Short Selling Information
The latest short interest is 11,332, so 0.26% of the outstanding shares have been sold short.
| Short Interest | 11,332 |
| Short Previous Month | 12,224 |
| Short % of Shares Out | 0.26% |
| Short % of Float | 0.35% |
| Short Ratio (days to cover) | 0.60 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.53M |
| Pretax Income | -5.00M |
| Net Income | -5.00M |
| EBITDA | -4.86M |
| EBIT | -4.89M |
| Earnings Per Share (EPS) | -$1.15 |
Balance Sheet
The company has $4.06 million in cash and no debt, giving a net cash position of $4.06 million or $0.91 per share.
| Cash & Cash Equivalents | 4.06M |
| Total Debt | n/a |
| Net Cash | 4.06M |
| Net Cash Per Share | $0.91 |
| Equity / Book Value | 3.67M |
| Book Value Per Share | 0.83 |
| Working Capital | 3.54M |
Cash Flow
In the last 12 months, operating cash flow was -$3.70 million and capital expenditures -$149,775, giving a free cash flow of -$3.85 million.
| Operating Cash Flow | -3.70M |
| Capital Expenditures | -149,775 |
| Free Cash Flow | -3.85M |
| FCF Per Share | -$0.89 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PTIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.62% |
| Shareholder Yield | -0.62% |
| Earnings Yield | -87.40% |
| FCF Yield | -67.35% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 23, 2023. It was a reverse split with a ratio of 1:4.
| Last Split Date | Mar 23, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |